Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M65.3Revenue (TTM) $M6.0Net Margin (%)-465.6Altman Z-Score-20.8
Enterprise Value $M47.9EPS (TTM) $-0.5Operating Margin %-435.9Piotroski F-Score2
P/E(ttm)--Beneish M-Score-0.8Pre-tax Margin (%)-463.9Higher ROA y-yN
Price/Book18.310-y EBITDA Growth Rate %--Quick Ratio5.0Cash flow > EarningsY
Price/Sales8.45-y EBITDA Growth Rate %--Current Ratio5.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-72.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-221.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M75.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AVEO is held by these investors:



AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dallas Matthew DVP, Finance 2015-01-16Sell3,075$0.820view
Gyuris JenoSVP, Chief Scientific Officer 2015-01-07Sell4,484$0.82.5view
Vittiglio JosephSVP, General Counsel 2015-01-07Sell4,484$0.82.5view
Dallas Matthew DVP, Finance 2015-01-07Sell519$0.82.5view
BAILEY MICHAEL PPresident & CEO 2015-01-07Sell4,484$0.82.5view
Dallas Matthew DVP, Finance 2014-07-01Sell0$02.5view
BAILEY MICHAEL PChief Business Officer 2014-01-30Sell5,430$1.64-50view
Slichenmyer WilliamChief Medical Officer 2014-01-30Sell5,430$1.64-50view
Gyuris JenoSVP, Chief Scientific Officer 2014-01-30Sell5,430$1.64-50view
Vittiglio JosephSVP, General Counsel 2014-01-30Sell5,430$1.64-50view

Quarterly/Annual Reports about AVEO:

    News about AVEO:

    Articles On GuruFocus.com
    Wild Card Wonders, Shopping for 52-Week Lows Sep 28 2013 
    Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low Sep 03 2013 
    Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA Dec 16 2012 
    Seth Klarman’s Baupost Group Buys Microsoft Corp., BP, Allied Nevada Gold, Sells Audiovox Corp. Aug 12 2011 
    Seth Klarman’s Baupost Group Q1 Portfolio Update; Buys ANV, SCMR, PDLI, AVEO May 14 2011 
    AVEO Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 11 2011 
    Two Picks from Seth Klarman: PDLI, AVEO Feb 22 2011 
    Hedge Fund Baupost Group buys PDLI, AVEO, ALR, Sells LSTZA, UFS, SLRC, EXXI Feb 11 2011 

    More From Other Websites
    Aveo Cancer Drug Tivozanib Clears Safety Review Feb 24 2017
    AVEO Announces TIVO-3 Passes The First Safety Monitoring Committee Safety Review Feb 23 2017
    AVEO Announces Clinical and Regulatory Updates for Tivozanib Feb 09 2017
    AVEO to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jan 12 2017
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement Jan 05 2017
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Jan 04 2017
    ETFs with exposure to AVEO Pharmaceuticals, Inc. : December 22, 2016 Dec 22 2016
    How AVEO Pharmaceuticals, Inc. (AVEO) Stacks Up Against Its Peers? Dec 13 2016
    ETFs with exposure to AVEO Pharmaceuticals, Inc. : December 12, 2016 Dec 12 2016
    AVEO Partner Submits Response to Questions on Tivozanib Nov 29 2016
    AVEO Announces Submission of Responses to the EMA Day 120 List of Questions for Marketing... Nov 28 2016
    AVEO to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 22 2016
    AVEO PHARMACEUTICALS INC Financials Nov 11 2016
    ETF’s with exposure to AVEO Pharmaceuticals, Inc. : November 10, 2016 Nov 10 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Nov 08 2016
    AVEO Pharmaceuticals, Inc. :AVEO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 Nov 08 2016
    AVEO Pharmaceuticals' (AVEO) Q3 Loss Lower than Expected Nov 07 2016
    AVEO (AVEO) Reports Narrower-than-Expected Loss in Q3 Nov 04 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 04 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)